Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations

References

• Ahlneck C, Waltersson JO. (1986). Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state. Acta Pharm Suec 23:139–50
   PubMedGoogle Scholar
• Ahuja N, Katare OP, Singh B. (2007). Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 65:26–38
   PubMed Web of Science ®Google Scholar
• Alam MA. (2012). Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates. Expert Opin Drug Deliv 9:1419–40
   PubMed Web of Science ®Google Scholar
• Ambike AA, Mahadik KR, Paradkar A. (2005). Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations. Pharm Res 22:990–8
   PubMed Web of Science ®Google Scholar
• Avachata A, Rauta V, Avachat A. (2012). Solubility and dissolution enhancement of Nebivolol hydrochloride 2 using hydrophilic carriers 3. Asian J Pharma Sci 7:337–45
   Google Scholar
• Barmpalexis P. (2013). Development of PVP/PEG mixtures as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique and optimization of dissolution using artificial neural networks. Eur J Pharm Biopharm 85:1219–31
   PubMed Web of Science ®Google Scholar
• Celestino MT. (2012). Rational use of antioxidants in solid oral pharmaceutical preparations. Brazil J Pharma Sci 48:405–15
   Web of Science ®Google Scholar
• Chokshi RJ. (2007). Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution-pros and cons. Drug Deliv 14:33–45
   PubMed Web of Science ®Google Scholar
• Dexia L. (2013). PLA/PEG-PPG-PEG/Dexamethasone implant prepared by hot-melt extrusion for controlled release of immunosuppressive drug to implantable medical devices, part 2: in vivo evaluation. Drug Deliv 20:134–42
   PubMed Web of Science ®Google Scholar
• Djuris J. (2013). Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design. J Pharm Pharmacol 66:232–43
   PubMed Web of Science ®Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, York P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 88:1182–90
   PubMed Web of Science ®Google Scholar
• Hong S, Shen S, Tan DCT, et al. (2014). High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods. Drug Deliv 22:1–12
   PubMed Web of Science ®Google Scholar
• Hu R, Zhu J, Chen G. (2006). Preparation of sustained-release simvastatin microspheres by the spherical crystallization technique. Asian J Pharm Sci 1:47–52
   Google Scholar
• Jijun F. (2011). Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 37:934–44
   PubMed Web of Science ®Google Scholar
• Jun SW. (2007). Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 66:413–21
   PubMed Web of Science ®Google Scholar
• Kadam Y. (2011). Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide. Colloids Surf B Biointerfaces 83:49–57
   PubMed Web of Science ®Google Scholar
• Kalivoda A, Fischbach M, Kleinebudde P. (2012). Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion. Int J Pharm 429:58–68
   PubMed Web of Science ®Google Scholar
• Linn M, Collnot EM, Djuric D. (2012). Soluplus as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci 45:336–43
   PubMed Web of Science ®Google Scholar
• Lobmann K. (2012). Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. Eur J Pharm Biopharm 81:159–69
   PubMed Web of Science ®Google Scholar
• Luo Y, Xu L, Tao X, et al. (2013). Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions. Drug Dev Ind Pharm 39:936–46
   PubMed Web of Science ®Google Scholar
• Mididoddi PK, Repka MA. (2007). Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm 66:95–105
   PubMed Web of Science ®Google Scholar
• Pandya P. (2008). Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation. AAPS PharmSciTech 9:1247–52
   PubMed Web of Science ®Google Scholar
• Priemel PA. (2013). Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures. Int J Pharm 456:301–16
   PubMed Web of Science ®Google Scholar
• Sarode AL. (2013). Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs. Eur J Pharm Biopharm 86:351–60
   PubMed Web of Science ®Google Scholar
• Shamma RN, Basha M. (2013). Solupluse (R): a novel polymeric solubilizer for optimization of Carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol 237:406–14
   Web of Science ®Google Scholar
• Silva TD. (2010). Preparation and characterization of solid dispersion of simvastatin. Drug Dev Ind Pharm 36:1348–55
   PubMed Web of Science ®Google Scholar
• Sousa M. (2010). Dynamical characterization of a cellulose acetate polysaccharide. J Phys Chem B 114:10939–53
   PubMed Web of Science ®Google Scholar
• Srinarong P, de Waard H, Frijlink HW. (2011). Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Expert Opin Drug Deliv 8:1121–40
   PubMed Web of Science ®Google Scholar
• Sun Y, Rui Y, Wenliang Z. (2008). Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm 359:144–9
   PubMed Web of Science ®Google Scholar
• Surampalli G, Nanjwade BK. (2014). Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation. Drug Deliv 31:1–15
   Google Scholar
• Tajber L, Corrigan OI, Healy AM. (2005). Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites – analysis of glass transition composition relationships. Eur J Pharm Sci 24:553–63
   PubMed Web of Science ®Google Scholar
• Telang C, Mujumdar S, Mathew M. (2009). Improved physical stability of amorphous state through acid base interactions. J Pharm Sci 98:2149–59
   PubMed Web of Science ®Google Scholar
• Yonemochi E, Inoue Y. (1999). Differences in crystallization behavior between quenched and ground amorphous ursodeoxycholic acid. Pharm Res 16:835–40
   PubMed Web of Science ®Google Scholar
• Yu H. (2013). Supersaturated polymeric micelles for oral cyclosporine a delivery. Eur J Pharm Biopharm 85:1325–36
   PubMed Web of Science ®Google Scholar
• Zhang F. (2009). Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Eur J Pharm Biopharm 71:64–70
   PubMed Web of Science ®Google Scholar
• Zhang K. (2013). Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Eur J Pharm Biopharm 85:1285–92
   PubMed Web of Science ®Google Scholar